Literature DB >> 7073943

Retinoma: spontaneous regression of retinoblastoma or benign manifestation of the mutation?

B L Gallie, R M Ellsworth, D H Abramson, R A Phillips.   

Abstract

Non-progressive retinal lesions, observed in patients known to carry the gene for retinoblastoma, have in the past been called "spontaneous regression" of retinoblastoma. This term suggests shrinkage of a malignant growth, perhaps in response to some host defence mechanism. On the basis of observations on 30 patients, we propose that the term "retinoma" would be less presumptive and more suitable. Retinoma is clinically defined as a translucent, grey, elevated mass extending into the vitreous from the retina, frequently associated with calcified foci and pigment-epithelium hyperplasia. The diagnosis of retinoma strongly suggests the presence of the retinoblastoma gene, necessitating genetic counselling and frequent observation of the retinas in the individual and his offspring. We suggest that the same mutations can cause either retinoma or retinoblastoma: benign hyperplastic nodules or retinoma when the mutations occur in relatively mature retinoblasts; and malignant retinoblastoma when the same mutations arise in immature retinoblasts.

Entities:  

Mesh:

Year:  1982        PMID: 7073943      PMCID: PMC2010981          DOI: 10.1038/bjc.1982.87

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  13 in total

1.  Spontaneous regression of retinoblastoma.

Authors:  A A Khodadoust; H M Roozitalab; R E Smith; W R Green
Journal:  Surv Ophthalmol       Date:  1977 May-Jun       Impact factor: 6.048

2.  [Two cases of the spontaneous healing of retinal gliomas].

Authors:  W WUSTENBERG
Journal:  Klin Monbl Augenheilkd Augenarztl Fortbild       Date:  1950

3.  [Radiotherapy of glioma of the retina].

Authors:  A SEUSS; E STUZ
Journal:  Strahlentherapie       Date:  1951

4.  Histology and spontaneous regression of retinoblastoma.

Authors:  J Lindley; S Smith
Journal:  Trans Ophthalmol Soc U K       Date:  1974

5.  Bilateral spontaneous regression of retinoblastoma.

Authors:  W G Pearce; J G Gillan
Journal:  Can J Ophthalmol       Date:  1972-04       Impact factor: 1.882

6.  Spontaneous regression of retinoblastoma. A report of two cases.

Authors:  A T Karsgaard
Journal:  Can J Ophthalmol       Date:  1971-07       Impact factor: 1.882

7.  A cause of radioresistance in retinoblastoma: photoreceptor differentiation.

Authors:  M O Ts'o; L E Zimmerman; B S Fine; R M Ellsworth
Journal:  Trans Am Acad Ophthalmol Otolaryngol       Date:  1970 Sep-Oct

8.  Sounding board. Regression of neuroblastoma IV-S: a genetic hypothesis.

Authors:  A G Knudson; A T Meadows
Journal:  N Engl J Med       Date:  1980-05-29       Impact factor: 91.245

9.  Mutation and cancer: statistical study of retinoblastoma.

Authors:  A G Knudson
Journal:  Proc Natl Acad Sci U S A       Date:  1971-04       Impact factor: 11.205

10.  Retinoblastoma undergoing spontaneous regression. Calcifying agent suggested in treatment of retinoblastoma.

Authors:  F H Verhoeff
Journal:  Am J Ophthalmol       Date:  1966-09       Impact factor: 5.258

View more
  39 in total

1.  Oncogenic point mutations in exon 20 of the RB1 gene in families showing incomplete penetrance and mild expression of the retinoblastoma phenotype.

Authors:  Z Onadim; A Hogg; P N Baird; J K Cowell
Journal:  Proc Natl Acad Sci U S A       Date:  1992-07-01       Impact factor: 11.205

2.  Genetic counselling in retinoblastoma: importance of ocular fundus examination of first degree relatives and linkage analysis.

Authors:  Z Onadim; P G Hykin; J L Hungerford; J K Cowell
Journal:  Br J Ophthalmol       Date:  1991-03       Impact factor: 4.638

3.  Two masquerade presentations of retinoblastoma.

Authors:  Andrea Lembo; Francesco Pichi; Elisabetta Santangelo; Paola Carrai; Theodora Hadjistilianou; Massimiliano Serafino; Paolo Nucci
Journal:  Int Ophthalmol       Date:  2015-10-08       Impact factor: 2.031

4.  Deletion of RB exons 24 and 25 causes low-penetrance retinoblastoma.

Authors:  R Bremner; D C Du; M J Connolly-Wilson; P Bridge; K F Ahmad; H Mostachfi; D Rushlow; J M Dunn; B L Gallie
Journal:  Am J Hum Genet       Date:  1997-09       Impact factor: 11.025

Review 5.  Retinoblastoma, the visible CNS tumor: A review.

Authors:  Helen Dimaras; Timothy W Corson
Journal:  J Neurosci Res       Date:  2018-01-03       Impact factor: 4.164

6.  Incomplete penetrance of familial retinoblastoma linked to germ-line mutations that result in partial loss of RB function.

Authors:  G A Otterson; W d Chen; A B Coxon; S N Khleif; F J Kaye
Journal:  Proc Natl Acad Sci U S A       Date:  1997-10-28       Impact factor: 11.205

7.  Application of intragenic DNA probes in prenatal screening for retinoblastoma gene carriers in the United Kingdom.

Authors:  Z O Onadim; C D Mitchell; P C Rutland; B G Buckle; M Jay; J L Hungerford; K Harper; J K Cowell
Journal:  Arch Dis Child       Date:  1990-07       Impact factor: 3.791

8.  Retinoblastoma. Fifty years of progress. The LXXI Edward Jackson Memorial Lecture.

Authors:  Hans E Grossniklaus
Journal:  Am J Ophthalmol       Date:  2014-07-24       Impact factor: 5.258

9.  Deletion of chromosome region 13q14 is transmissible and does not always predispose to retinoblastoma.

Authors:  J K Cowell; P Rutland; J Hungerford; M Jay
Journal:  Hum Genet       Date:  1988-09       Impact factor: 4.132

10.  Differential diagnosis of leukocoria and strabismus, first presenting signs of retinoblastoma.

Authors:  Aubin Balmer; Francis Munier
Journal:  Clin Ophthalmol       Date:  2007-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.